Skip to main navigation Skip to search Skip to main content

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury

Research output: Contribution to journalArticlepeer-review

20 Scopus citations
Original languageEnglish
Pages (from-to)1807-1808
Number of pages2
JournalNeural Regeneration Research
Volume12
Issue number11
DOIs
StatePublished - Nov 2017

Bibliographical note

Funding Information:
This work was funded by NIH R21NS096670 (AGR), Craig H. Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

Funding

This work was funded by NIH R21NS096670 (AGR), Craig H. Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

FundersFunder number
NIH/NINDS2P30NS051220
National Institutes of Health (NIH)476719, R21NS096670
Nurses Organization of Veterans Affairs01BX003405
University of Kentucky
Kentucky Spinal Cord and Head Injury Research Trust15-14A

    ASJC Scopus subject areas

    • Developmental Neuroscience

    Fingerprint

    Dive into the research topics of 'Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury'. Together they form a unique fingerprint.

    Cite this